-
1
-
-
70349636522
-
-
World Health Organization, Accessed January 14
-
World Health Organization. Global Alert and Response: Hepatitis C. http://www.who.int/csr/disease/hepatitis/whocdscsrlyo2003/en/index1.html. Accessed January 14, 2013
-
(2013)
Global Alert and Response: Hepatitis C
-
-
-
2
-
-
79951545875
-
A review of the treatment of chronic hepatitis C virus infection in cirrhosis
-
[PMID: 21316532 DOI: 10.1016/ j.clinthera.2010.12.013]
-
Vezali E, Aghemo A, Colombo M. A review of the treatment of chronic hepatitis C virus infection in cirrhosis. Clin Ther 2010; 32: 2117-2138. [PMID: 21316532 DOI: 10.1016/ j.clinthera.2010.12.013]
-
(2010)
Clin Ther
, vol.32
, pp. 2117-2138
-
-
Vezali, E.1
Aghemo, A.2
Colombo, M.3
-
3
-
-
78649949431
-
Forecasting the morbidity and mortality associated with prevalent cases of pre-cirrhotic chronic hepatitis C in the United States
-
[PMID: 20739252 DOI: 10.1016/j.dld.2010.05.006]
-
Rein DB, Wittenborn JS, Weinbaum CM, Sabin M, Smith BD, Lesesne SB. Forecasting the morbidity and mortality associated with prevalent cases of pre-cirrhotic chronic hepatitis C in the United States. Dig Liver Dis 2011; 43: 66-72. [PMID: 20739252 DOI: 10.1016/j.dld.2010.05.006]
-
(2011)
Dig Liver Dis
, vol.43
, pp. 66-72
-
-
Rein, D.B.1
Wittenborn, J.S.2
Weinbaum, C.M.3
Sabin, M.4
Smith, B.D.5
Lesesne, S.B.6
-
4
-
-
0035913229
-
Treatment of chronic hepatitis C in active drug users
-
[PMID: 11463020]
-
Davis GL, Rodrigue JR. Treatment of chronic hepatitis C in active drug users. N Engl J Med 2001; 345: 215-217. [PMID: 11463020]
-
(2001)
N Engl J Med
, vol.345
, pp. 215-217
-
-
Davis, G.L.1
Rodrigue, J.R.2
-
5
-
-
84873491855
-
Integrating phylodynamics and epidemiology to estimate transmission diversity in viral epidemics
-
[PMID: 23382662 DOI: 10.1371/journal. pcbi.1002876]
-
Magiorkinis G, Sypsa V, Magiorkinis E, Paraskevis D, Katsoulidou A, Belshaw R, Fraser C, Pybus OG, Hatzakis A. Integrating phylodynamics and epidemiology to estimate transmission diversity in viral epidemics. PLoS Comput Biol 2013; 9: e1002876. [PMID: 23382662 DOI: 10.1371/journal. pcbi.1002876]
-
(2013)
PLoS Comput Biol
, vol.9
-
-
Magiorkinis, G.1
Sypsa, V.2
Magiorkinis, E.3
Paraskevis, D.4
Katsoulidou, A.5
Belshaw, R.6
Fraser, C.7
Pybus, O.G.8
Hatzakis, A.9
-
6
-
-
0036893172
-
National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C 2002 (June 10-12, 2002)
-
[PMID: 12454863]
-
National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C 2002 (June 10-12, 2002). Gastroenterology 2002; 123: 2082-2099. [PMID: 12454863]
-
(2002)
Gastroenterology
, vol.123
, pp. 2082-2099
-
-
-
7
-
-
30044432484
-
American Gastroenterological Association technical review on the management of hepatitis C
-
quiz 214-7, [PMID: 16401486]
-
Dienstag JL, McHutchison JG. American Gastroenterological Association technical review on the management of hepatitis C. Gastroenterology 2006; 130: 231-64 quiz 214-7. [PMID: 16401486]
-
(2006)
Gastroenterology
, vol.130
, pp. 231-264
-
-
Dienstag, J.L.1
McHutchison, J.G.2
-
8
-
-
65449136656
-
Diagnosis, management, and treatment of hepatitis C: An update
-
[PMID: 19330875 DOI: 10.1002/hep.22759]
-
Ghany MG, Strader DB, Thomas DL, Seeff LB. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009; 49: 1335-1374. [PMID: 19330875 DOI: 10.1002/hep.22759]
-
(2009)
Hepatology
, vol.49
, pp. 1335-1374
-
-
Ghany, M.G.1
Strader, D.B.2
Thomas, D.L.3
Seeff, L.B.4
-
9
-
-
16844384955
-
Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users
-
[PMID: 15768335]
-
Edlin BR, Kresina TF, Raymond DB, Carden MR, Gourevitch MN, Rich JD, Cheever LW, Cargill VA. Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users. Clin Infect Dis 2005; 40 Suppl 5: S276-S285. [PMID: 15768335]
-
(2005)
Clin Infect Dis
, vol.40
, Issue.SUPPL. 5
-
-
Edlin, B.R.1
Kresina, T.F.2
Raymond, D.B.3
Carden, M.R.4
Gourevitch, M.N.5
Rich, J.D.6
Cheever, L.W.7
Cargill, V.A.8
-
10
-
-
68549115309
-
Antiviral treatment for chronic hepatitis C in illicit drug users: A systematic review
-
[PMID: 19578232]
-
Zanini B, Lanzini A. Antiviral treatment for chronic hepatitis C in illicit drug users: a systematic review. Antivir Ther 2009; 14: 467-479. [PMID: 19578232]
-
(2009)
Antivir Ther
, vol.14
, pp. 467-479
-
-
Zanini, B.1
Lanzini, A.2
-
11
-
-
34447564035
-
Treatment for hepatitis C virus in injection drug users on opioid replacement therapy: A prospective multicentre study
-
[PMID: 17625449]
-
Belfiori B, Chiodera A, Ciliegi P, Tosti A, Baldelli F, Stagni G, Francisci D. Treatment for hepatitis C virus in injection drug users on opioid replacement therapy: a prospective multicentre study. Eur J Gastroenterol Hepatol 2007; 19: 731-732. [PMID: 17625449]
-
(2007)
Eur J Gastroenterol Hepatol
, vol.19
, pp. 731-732
-
-
Belfiori, B.1
Chiodera, A.2
Ciliegi, P.3
Tosti, A.4
Baldelli, F.5
Stagni, G.6
Francisci, D.7
-
12
-
-
33846937792
-
Effectiveness of a multi-disciplinary standardized management model in the treatment of chronic hepatitis C in drug addicts engaged in detoxification programmes
-
[PMID: 17298650]
-
Guadagnino V, Trotta MP, Montesano F, Babudieri S, Caroleo B, Armignacco O, Carioti J, Maio G, Monarca R, Antinori A. Effectiveness of a multi-disciplinary standardized management model in the treatment of chronic hepatitis C in drug addicts engaged in detoxification programmes. Addiction 2007; 102: 423-431. [PMID: 17298650]
-
(2007)
Addiction
, vol.102
, pp. 423-431
-
-
Guadagnino, V.1
Trotta, M.P.2
Montesano, F.3
Babudieri, S.4
Caroleo, B.5
Armignacco, O.6
Carioti, J.7
Maio, G.8
Monarca, R.9
Antinori, A.10
-
13
-
-
79960369225
-
Recommendations for the prevention, diagnosis, and treatment of chronic hepatitis B and C in special population groups (migrants, intravenous drug users and prison inmates)
-
[PMID: 21256097 DOI: 10.1016/j.dld.2010.12.004]
-
Almasio PL, Babudieri S, Barbarini G, Brunetto M, Conte D, Dentico P, Gaeta GB, Leonardi C, Levrero M, Mazzotta F, Morrone A, Nosotti L, Prati D, Rapicetta M, Sagnelli E, Scotto G, Starnini G. Recommendations for the prevention, diagnosis, and treatment of chronic hepatitis B and C in special population groups (migrants, intravenous drug users and prison inmates). Dig Liver Dis 2011; 43: 589-595. [PMID: 21256097 DOI: 10.1016/j.dld.2010.12.004]
-
(2011)
Dig Liver Dis
, vol.43
, pp. 589-595
-
-
Almasio, P.L.1
Babudieri, S.2
Barbarini, G.3
Brunetto, M.4
Conte, D.5
Dentico, P.6
Gaeta, G.B.7
Leonardi, C.8
Levrero, M.9
Mazzotta, F.10
Morrone, A.11
Nosotti, L.12
Prati, D.13
Rapicetta, M.14
Sagnelli, E.15
Scotto, G.16
Starnini, G.17
-
14
-
-
79951541896
-
Effectiveness and tolerability of combination treatment of chronic hepatitis C in illicit drug users: Meta-analysis of prospective studies
-
[PMID: 21316533 DOI: 10.1016/ S0149-2918(11)00021-X]
-
Zanini B, Covolo L, Donato F, Lanzini A. Effectiveness and tolerability of combination treatment of chronic hepatitis C in illicit drug users: meta-analysis of prospective studies. Clin Ther 2010; 32: 2139-2159. [PMID: 21316533 DOI: 10.1016/ S0149-2918(11)00021-X]
-
(2010)
Clin Ther
, vol.32
, pp. 2139-2159
-
-
Zanini, B.1
Covolo, L.2
Donato, F.3
Lanzini, A.4
-
15
-
-
10744228140
-
CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment
-
[PMID: 12903007]
-
Trotti A, Colevas AD, Setser A, Rusch V, Jaques D, Budach V, Langer C, Murphy B, Cumberlin R, Coleman CN, Rubin P. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 2003; 13: 176-181. [PMID: 12903007]
-
(2003)
Semin Radiat Oncol
, vol.13
, pp. 176-181
-
-
Trotti, A.1
Colevas, A.D.2
Setser, A.3
Rusch, V.4
Jaques, D.5
Budach, V.6
Langer, C.7
Murphy, B.8
Cumberlin, R.9
Coleman, C.N.10
Rubin, P.11
-
16
-
-
0036788338
-
Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C
-
[PMID: 12360468]
-
McHutchison JG, Manns M, Patel K, Poynard T, Lindsay KL, Trepo C, Dienstag J, Lee WM, Mak C, Garaud JJ, Albrecht JK. Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C. Gastroenterology 2002; 123: 1061-1069. [PMID: 12360468]
-
(2002)
Gastroenterology
, vol.123
, pp. 1061-1069
-
-
McHutchison, J.G.1
Manns, M.2
Patel, K.3
Poynard, T.4
Lindsay, K.L.5
Trepo, C.6
Dienstag, J.7
Lee, W.M.8
Mak, C.9
Garaud, J.J.10
Albrecht, J.K.11
-
17
-
-
0035934568
-
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial
-
[PMID: 11583749]
-
Manns MP, McHutchison JG, Gordon SC, Rustgi VK, Shiffman M, Reindollar R, Goodman ZD, Koury K, Ling M, Albrecht JK. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 2001; 358: 958-965. [PMID: 11583749]
-
(2001)
Lancet
, vol.358
, pp. 958-965
-
-
Manns, M.P.1
McHutchison, J.G.2
Gordon, S.C.3
Rustgi, V.K.4
Shiffman, M.5
Reindollar, R.6
Goodman, Z.D.7
Koury, K.8
Ling, M.9
Albrecht, J.K.10
-
18
-
-
0037179698
-
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection
-
[PMID: 12324553]
-
Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Gonçales FL, Häussinger D, Diago M, Carosi G, Dhumeaux D, Craxi A, Lin A, Hoffman J, Yu J. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002; 347: 975-982. [PMID: 12324553]
-
(2002)
N Engl J Med
, vol.347
, pp. 975-982
-
-
Fried, M.W.1
Shiffman, M.L.2
Reddy, K.R.3
Smith, C.4
Marinos, G.5
Gonçales, F.L.6
Häussinger, D.7
Diago, M.8
Carosi, G.9
Dhumeaux, D.10
Craxi, A.11
Lin, A.12
Hoffman, J.13
Yu, J.14
-
19
-
-
0037308288
-
Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups
-
[PMID: 12540795]
-
Schaefer M, Schmidt F, Folwaczny C, Lorenz R, Martin G, Schindlbeck N, Heldwein W, Soyka M, Grunze H, Koenig A, Loeschke K. Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups. Hepatology 2003; 37: 443-451. [PMID: 12540795]
-
(2003)
Hepatology
, vol.37
, pp. 443-451
-
-
Schaefer, M.1
Schmidt, F.2
Folwaczny, C.3
Lorenz, R.4
Martin, G.5
Schindlbeck, N.6
Heldwein, W.7
Soyka, M.8
Grunze, H.9
Koenig, A.10
Loeschke, K.11
-
20
-
-
36348986800
-
Hepatitis C treatment in "difficult-to-treat" psychiatric patients with pegylated interferon-alpha and ribavirin: Response and psychiatric side effects
-
[PMID: 17668880]
-
Schaefer M, Hinzpeter A, Mohmand A, Janssen G, Pich M, Schwaiger M, Sarkar R, Friebe A, Heinz A, Kluschke M, Ziemer M, Gutsche J, Weich V, Halangk J, Berg T. Hepatitis C treatment in "difficult-to-treat" psychiatric patients with pegylated interferon-alpha and ribavirin: response and psychiatric side effects. Hepatology 2007; 46: 991-998. [PMID: 17668880]
-
(2007)
Hepatology
, vol.46
, pp. 991-998
-
-
Schaefer, M.1
Hinzpeter, A.2
Mohmand, A.3
Janssen, G.4
Pich, M.5
Schwaiger, M.6
Sarkar, R.7
Friebe, A.8
Heinz, A.9
Kluschke, M.10
Ziemer, M.11
Gutsche, J.12
Weich, V.13
Halangk, J.14
Berg, T.15
-
21
-
-
34547942089
-
Adherence to hepatitis C treatment in recovering heroin users maintained on methadone
-
[PMID: 17700258]
-
Sylvestre DL, Clements BJ. Adherence to hepatitis C treatment in recovering heroin users maintained on methadone. Eur J Gastroenterol Hepatol 2007; 19: 741-747. [PMID: 17700258]
-
(2007)
Eur J Gastroenterol Hepatol
, vol.19
, pp. 741-747
-
-
Sylvestre, D.L.1
Clements, B.J.2
-
22
-
-
79953772327
-
Clinical experience with the treatment of hepatitis C infection in patients on opioid pharmacotherapy
-
[PMID: 21205057 DOI: 10.1111/ j.1360-0443.2010.03347.x]
-
Sasadeusz JJ, Dore G, Kronborg I, Barton D, Yoshihara M, Weltman M. Clinical experience with the treatment of hepatitis C infection in patients on opioid pharmacotherapy. Addiction 2011; 106: 977-984. [PMID: 21205057 DOI: 10.1111/ j.1360-0443.2010.03347.x]
-
(2011)
Addiction
, vol.106
, pp. 977-984
-
-
Sasadeusz, J.J.1
Dore, G.2
Kronborg, I.3
Barton, D.4
Yoshihara, M.5
Weltman, M.6
-
23
-
-
67649946750
-
Hepatitis C virus and alcohol
-
[PMID: 19387918 DOI:10.1055/s-0029-1214374]
-
Siu L, Foont J, Wands JR. Hepatitis C virus and alcohol. Semin Liver Dis 2009; 29: 188-199. [PMID: 19387918 DOI:10.1055/s-0029-1214374]
-
(2009)
Semin Liver Dis
, vol.29
, pp. 188-199
-
-
Siu, L.1
Foont, J.2
Wands, J.R.3
-
24
-
-
84862703932
-
Predictors of virologic response with telaprevir-based combination treatment in HCV genotype 1-infected patients with prior peginterferon/ribavirin treatment failure: Post-hoc analysis of the phase III realize study
-
Berg T, Andreone P, Pol S, Roberts S, Younossi Z, Diago M, Lawitz EJ, Focaccia R, Foster GR, Horban A, LonjonDomanec I, DeMasi R, Picchio G, Witek J, Zeuzem S. Predictors of virologic response with telaprevir-based combination treatment in HCV genotype 1-infected patients with prior peginterferon/ribavirin treatment failure: post-hoc analysis of the phase III realize study. Hepatology 2011; 54: 375A-376A
-
(2011)
Hepatology
, vol.54
-
-
Berg, T.1
Andreone, P.2
Pol, S.3
Roberts, S.4
Younossi, Z.5
Diago, M.6
Lawitz, E.J.7
Focaccia, R.8
Foster, G.R.9
Horban, A.10
Lonjondomanec, I.11
Demasi, R.12
Picchio, G.13
Witek, J.14
Zeuzem, S.15
-
25
-
-
0034975294
-
HCV genotype and "silent" HBV coinfection: Two main risk factors for a more severe liver disease
-
[PMID: 11424125]
-
Sagnelli E, Coppola N, Scolastico C, Mogavero AR, Filippini P, Piccinino F. HCV genotype and "silent" HBV coinfection: two main risk factors for a more severe liver disease. J Med Virol 2001; 64: 350-355. [PMID: 11424125]
-
(2001)
J Med Virol
, vol.64
, pp. 350-355
-
-
Sagnelli, E.1
Coppola, N.2
Scolastico, C.3
Mogavero, A.R.4
Filippini, P.5
Piccinino, F.6
|